Spinal Interbody Fusion Market is expected to grow with a CAGR 3.4% from 2022 to 2028

As stated in our extensive report; providing insights by Segments viz.Type, Surgery, End User and Region; the Global Spinal Interbody Fusion Market accounted for USD 7.1 Billion in the year 2021.

“Key Factors Likely to Drive Growth of Spinal Interbody Fusion Market”

Spinal fusion devices are used to give strength to the spinal structure, which has lost stability because of a fracture, degenerative issues of the spine, trauma, tumors, and deformity. Spinal cord injuries majorly appear due to diverse reasons inclusive of a blocked blood supply, infections, injuries, and compression over a fractured bone or a tumor. Spinal fusion devices have revolutionary locking mechanisms and screw systems that can have self-drilling and self-tapping functions, crafted from current production cloth and titanium alloy, and single and double holes in keeping with vertebrae through which the screw fixation is done.

Factors accountable for spinal deformities encompass weight, diet, smoking, and different lifestyle factors. Early-onset of degenerative spinal changes is attributed to the toxins in cigarette smoke damaging the cartilage of the spine. The increasing occurrence of spinal deformities because of an unhealthy probability and excessive probability of disc herniation is anticipated to drive the growth of the market in the future.

The rise in the occurrence of spinal disorders, improvements in backbone surgery and the shift toward minimally invasive spine procedures drive the increase of the worldwide spinal fusion devices market. However, unfavorable reimbursement scenarios and stringent regulatory approval procedures restrain the market increase. On the opposite hand, advancements in augmented and virtual reality, endoscopic surgery, and 3-D have revealed implants, creating new possibilities in the coming years.

North Americaheld the largest market share due to the rise in the incidence of lower back pain and spinal injuries in this region. The increase in the United States is pushed by technological advancement, elderly patients looking forward to better ranges of function, and compensation models that incentivize complex fusion surgical operations and have helped in driving the increase in spinal surgical operations.

Some of the key players in the Global Spinal Interbody Fusion Market include Zimmer Biomet Holdings Inc., Alphatec Holdings Inc., B. Braun Melsungen AG, Exactech Inc., Globus Medical Inc., Johnson & Johnson, Medtronic PLC, Nuvasive Inc., Orthofix International N.V., Stryker Corporation and others.